FIELD: pharmaceutics.
SUBSTANCE: invention relates to 1-[(5-nitrofuran-2-yl)carbonyl]-2'-cyclohexyl-1H,7'H-spiro[azetidine-3,5'-furo[3,4-d]pyrimidine] of formula 1, having anti-tuberculosis activity with respect to a multidrug-resistant agent, and a method for preparing it.
EFFECT: novel compound of formula 1 is obtained, which can be used as a substance for treating multidrug-resistant tuberculosis with low toxicity and good tolerance.
2 cl, 6 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PHENYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824815C1 |
1-[(5-NITROFURAN-2-YL)CARBONYL]-2'-PROPYL-1H,7'H-SPIRO[AZETIDINE-3,5'-FURO[3,4-D]PYRIMIDINE], HAVING ANTI-TUBERCULOSIS ACTIVITY IN WITH RESPECT TO MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2824817C1 |
COMPOUND OF 8-(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)-6-(METHYLSULPHONYL)-2-(5-NITRO-2-FUROYL)-2,6-DIAZASPIRO[3.4]OCTANE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST MULTIDRUG-RESISTANT TUBERCULOSIS AGENT, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825646C1 |
(4-(3-HYDROXYPHENYL)PIPERAZINE-1-YL)(5-NITROFURAN-2-YL)METHANON, WHICH HAS ANTITUBERCULAR ACTIVITY AGAINST THE CAUSATIVE AGENT OF MULTIDRUG-RESISTANT TUBERCULOSIS, AND THE METHOD FOR ITS PREPARATION | 2021 |
|
RU2784399C1 |
5-METHYL-7-(3-NITRO-[1,2,4]TRIAZOL-1-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, HAVING ANTI-TUBERCULOSIS ACTIVITY AGAINST THE AGENT WITH MULTIPLE DRUG RESISTANCE, AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2705591C1 |
ANTITUBERCULOSIS AGENT BASED ON 4'-HYDROXY-1'-(2-HYDROXYPHENYL)-3'-ACYL-SPIRO[BENZO[b][1,4]THIAZINE-2,2'-PYRROLE]-3,5'(1 'H,4H)-DIONES | 2023 |
|
RU2806097C1 |
ANTITUBERCULAR AGENT BASED ON A PYRIDOXINE DERIVATIVE | 2021 |
|
RU2772219C1 |
ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE | 2013 |
|
RU2545458C2 |
METHOD FOR CARRYING OUT TUBERCULOSTATIC TESTS IN PATIENTS WITH PULMONARY TUBERCULOSIS FOR LABORATORY SUBSTANTIATION OF PERSONIFIED TREATMENT | 2017 |
|
RU2686732C2 |
N-(2-AMINOPURIN-6-YL)GLYCYL-(S)-GLUTAMIC ACID, HAVING ANTI-TUBERCULOSIS ACTIVITY | 2015 |
|
RU2604068C1 |
Authors
Dates
2024-08-28—Published
2023-09-11—Filed